Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro.
Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026.
Update of the Drug Resistance Mutations in HIV-1.
HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
Improving strategies for detecting genetic patterns of disease susceptibility in association studies.
Design, expression, and processing of epitomized hepatitis C virus-encoded CTL epitopes.
The effect of oxidative environment on immunosuppressive properties of human seminal plasma.
Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection.
Central role of reverting mutations in HLA associations with human immunodeficiency virus set point.
Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study.